{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:19:32Z","timestamp":1785842372391,"version":"3.56.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1097\/aog.0000000000000669","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T13:32:53Z","timestamp":1420723973000},"page":"330-337","source":"Crossref","is-referenced-by-count":193,"title":["Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening"],"prefix":"10.1097","volume":"125","author":[{"given":"Warner K.","family":"Huh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Ault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chelmow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane D.","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Goulart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco A. R.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter K.","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Stewart","family":"Massad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Mayeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Saslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herschel W.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Einstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210126","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":". Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"R2-8-20210126","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"S. Preventive Services Task Force. Screening for cervical cancer: U.S. preventive services task force recommendation statement.","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"R3-8-20210126","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":". 2006 consensus guidelines for the management of women with abnormal cervical screening tests.","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"R4-8-20210126","first-page":"147","article-title":". American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.","volume":"62","author":"Saslow","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R5-8-20210126","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":". Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"R6-8-20210126","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/bjc.2011.581","article-title":". HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications.","volume":"106","author":"Rijkaart","year":"2012","journal-title":"Br J Cancer"},{"key":"R7-8-20210126","doi-asserted-by":"crossref","first-page":"e7789","DOI":"10.1136\/bmj.e7789","article-title":". Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland.","volume":"345","author":"Leinonen","year":"2012","journal-title":"BMJ"},{"key":"R8-8-20210126","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/ijc.27850","article-title":"The HPV test has similar sensitivity but more overdiagnosis than the Pap test-a randomised health services study on cervical cancer screening in Finland.","volume":"132","author":"Malila","year":"2013","journal-title":"Int J Cancer"},{"key":"R9-8-20210126","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ygyno.2012.01.036","article-title":"Primary high-risk HPV screening for cervical cancer in post-menopausal women.","volume":"125","author":"Gyllensten","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R10-8-20210126","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/bjc.2012.489","article-title":". Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trialthe HPV FOCAL Study.","volume":"107","author":"Ogilvie","year":"2012","journal-title":"Br J Cancer"},{"key":"R13-8-20210126","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":". Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"R14-8-20210126","doi-asserted-by":"crossref","first-page":"c1804","DOI":"10.1136\/bmj.c1804","article-title":". Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme.","volume":"340","author":"Anttila","year":"2010","journal-title":"BMJ"},{"key":"R15-8-20210126","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1470-2045(10)70256-4","article-title":". Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.","volume":"11","author":"Zhao","year":"2010","journal-title":"Lancet Oncol"},{"key":"R16-8-20210126","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ygyno.2012.10.017","article-title":"Accuracy of colposcopy management to detect CIN3 and invasive cancer in women with abnormal screening tests: results from a primary HPV screening project from 2006 to 2011 in Wolfsburg, Germany.","volume":"128","author":"Petry","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R17-8-20210126","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ijc.26056","article-title":". Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening.","volume":"130","author":"Rijkaart","year":"2012","journal-title":"Int J Cancer"},{"key":"R18-8-20210126","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":". Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"R19-8-20210126","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ejca.2011.01.008","article-title":". A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial.","volume":"47","author":"Kitchener","year":"2011","journal-title":"Eur J Cancer"},{"key":"R20-8-20210126","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":". Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol"},{"key":"R21-8-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/dju153","article-title":". Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.","volume":"106","author":"Gage","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R22-8-20210126","first-page":"45","article-title":". Primary cervical cancer truly negative for high-risk human papillomavirus is a rare but distinct entity that can affect virgins and young adolescents.","volume":"30","author":"Liebrich","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"key":"R23-8-20210126","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication.","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer"},{"key":"R24-8-20210126","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/LGT.0b013e3182a577c7","article-title":". Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction.","volume":"18","author":"Hopenhayn","year":"2014","journal-title":"J Low Genit Tract Dis"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000000669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:20:38Z","timestamp":1620944438000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201502000-00008"}},"subtitle":["Interim Clinical Guidance"],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000000669","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}